Following this spike, prescribing was relatively stable from September through November (0.01 percentage points per month), before increasing again from November to December (+0.04 points) and accelerating from December 2025 through February 2026 (+0.12 percentage points per month)
All GLP-1 RA products are available as subcutaneous injections, while semaglutide is also available as an oral tablet
Standard protocols start at a low dose (0.25 mg weekly) and titrate upward over 16 to 20 weeks
IV NAD therapies are not FDA-approved , have no standardized dosing, and may cause nausea, flushing, anxiety, or tachycardia
Lets break it down so you can be confident that youre using your semaglutide not just safely but also effectively
If the pancreatitis is caused by alcohol or is medication induced, GLP-1 RAs are not recommended, Chadha said